Exor N.V. (LON:0RKY)
72.26
+0.04 (0.06%)
At close: Dec 16, 2025
Exor N.V. Revenue
Exor N.V. had revenue of -557.00M EUR in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to -302.00M. In the year 2024, Exor N.V. had annual revenue of 15.40B, down -66.09%.
Revenue (ttm)
-302.00M EUR
Revenue Growth
-66.09%
P/S Ratio
-50.89
Revenue / Employee
-13.13M EUR
Employees
23
Market Cap
13.17B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.40B | -30.01B | -66.09% |
| Dec 31, 2023 | 45.41B | 3.56B | 8.51% |
| Dec 31, 2022 | 41.84B | 8.23B | 24.47% |
| Dec 31, 2021 | 33.62B | 6.83B | 25.47% |
| Dec 31, 2020 | 26.79B | -116.96B | -81.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |